Baylor Genetics PreSeek for Prenatal Multi-Gene Sequencing Screen

Baylor Genetics has launched PreSeek, a clinical non-invasive prenatal multi-gene sequencing screen. The test requires blood and/or saliva samples from each parent, then sequences cell-free fetal DNA for de novo disease-causing variants associated with select single-gene conditions affecting the skeletal, cardiac, and neurological systems. It is complementary to traditional prenatal screening tests, the company said.